quisinostat

General Information

Company	Johnson & Johnson
Description	Histone deacetylase (HDAC) inhibitor
Molecular Target
Mechanism of Action

Latest Stage of Development	Phase II
Indication	Cutaneous T cell lymphoma (CTCL)
Partner

Product Details

Archive Items are loading